per distribution in various organs. Elevations of copper in kidney, intestine, and connective tissue were accompanied by concomitant deficiency in other tissues. Copper deficiency, possible copper toxicity, and defective copper use have been advanced as possible causes of the multisystem lesions observed in patients with KHS (5) (6) (7) (8) .
Mice mutant at the x-linked mottled locus provide an accurate animal model of KHS (8) (9) (10) . A number of allelic mutations have been described designated as "blotchy," "brindled," and others, based on coat, color, pattern, and other features. The mutant mouse displays defective hair structure, decreased pigmentation, skeletal abnormalities, growth retardation, arterial aneurysms, and characteristics neurologic abnormalities. The concordance of these abnormalities with the characteristic features of KHS strongly suggests that the x-linked mutation in mouse and man is homologous, a notion supported by the fact that x-linked loci are highly conserved through evolution (1 1).
The liver is the major organ of copper metabolism in mammals. At autopsy, newborns and older infants with KHS have markedly reduced hepatic copper levels (7) . Kinetic studies with radiocopper in the mottled mouse have shown normal hepatic copper uptake, but defective retention with rapid loss of radiocopper from the liver (8, 13) . Defective retention of copper in the liver may reflect an alteration in hepatic copper transport or disposition, or excessive avidity of certain extrahepatic tissues for copper. Normal copper incorporation into ceruloplasmin in KHS and the mottled mouse (14, 15) suggests that hepatic disposition of copper by that route is unaffected by the KHS mutation.
To further characterize the nature of the hepatic defect in KHS, we studied hepatic disposition of copper in the mottled mouse. The results demonstrate defective biliary copper excretion and hepatic copper retention in the animal model for KHS, supporting the hypothesis that the basic defect in KHS involves disordered copper transport (2 1, 24, 25).
Abbreviations MATERIALS AND METHODS

KHS, kinky hair syndrome
Animals. Heterozygote females (Mob"/+) and normal male mice of strain C57BL/6J were purchased as breeding pairs from The Jackson Laboratories, Bar Harbor, ME. The mice were housed in a room set aside for mutant mice in the Animal Care Menkes' K H~ is a lethal x-linked neurodegenerative disorder Facility, University of California, San Francisco, where they were of copper metabolism featuring low serum copper levels and provided tap water and Purina Rat Chow (Ralston-Purina, St. decreased activities of cuproenzymes (1, 2) . The clinical rnani-MO) ad libitum.
lighting was set for l2 of daylight festations of K H~ were initially attributed to poor copper ab-by automatic timer. Studies were performed on postweaned adult sorption and resultant copper deficiency in affected tissues (3, heterozygotesj with age-and wt-matched homo-4 Bile was collected in hourly aliquots, and volume and bile acid content was measured. Data are expressed as mean + SEM. * Indicates that the controls and heterozygotes at the indicated time point can be distinguished at p = 0.048.
Controls
Heterozygotes Hemizygote mg of copper. Collected samples were counted directly in a catheter was sutured in place and connected to a syringe infusion gamma scintillation counter peaked for that isotope. 6 4 C~ counts pump. were corrected for decay (8) . Tests of statistical significance were
The gallbladder and porta hepatis were exposed through a made using the two-tailed t test (27). midline abdominal incision, and a secure ligature was placed Measurement of biliary 6 4 C~ excretion. Central venous cathe-around the common bile duct. A small incision was made in the ters were installed in 25-to 30-g mice under pentobarbital gallbladder through which a polyethylene catheter (outer diamanesthesia (50 mg/kg by intraperitoneal injection). The skin over eter 0.024 inches) was placed and securely sutured, with prompt the right side of the neck was shaved and the right internal initiation of bile drainage. The abdominal incision was closed, jugular vein isolated by blunt dissection through a 1-cm skin and the mouse placed in a restraint device for the duration of incision. After a distal ligature was tied in place, a small incision the experiment. Hydration and bile salt concentrations were was made in the vein and a polyethylene catheter (outer diameter maintained with continuous i. kidney, and heart were excised, thoroughly washed in normal saline, and prepared for scintillation counting. Results are ex- The cumulative biliary excretion of (j4Cu was strikingly lower in mutant mice compared with controls: control females excreted 24.7 k 1.5% whereas heterozygotic mutants excreted 6.5 + 1.3% of the injected dose during the study period (Fig. 2) . The single hemizygote excreted less than 2% of injected 6 4 C~. The pattern of biliary copper excretion differed in control and mutant mice. In controls, biliary excretion of 6 4 C~ increased sharply 1-2 h after injection, declined steadily thereafter, and returned to initial values by the 8th h (Fig. 3) . Excretion in heterozygotes remained less than 1 % of the injected dose with a minimal decline during the entire 8-h collection period. The control-paired hemizygote exhibited little copper excretion (Fig. 4) . As a measure of copper uptake by liver, accumulation of 6 4 C~ was measured at a series of time points postadministration of the radioactive metal in heterozygote and normal control female mice (Fig. 5) . The slopes of the regression lines for normal and mutant data points were not different when analyzed by twotailed t test ( p > 0.50). These data indicate that no differences were found in copper uptake in mutant versus control liver under the experimental conditions used in this study.
Determinations of 6 4 C~ accumulation in liver, cardiac muscle, and kidney were made 8 h after injection of 6 4 C~ and expressed per g organ wet wt. As shown in Table 1 , liver of heterozygote and control animals contained comparable amounts of copper, amounting to -30% of the injected cpm/g organ wt. Concentrations in cardiac muscle were also similar in heterozygote and control mice, albeit much lower than in liver, amounting to 1.5-2.2% of injected countslg tissue. In contrast, radiocopper accumulated in kidney in heterozygous mice was four to five times that recorded in control kidney after 8 h. 
DISCUSSION
Reduced liver copper content has been documented in human KHS (14) and in the mottled mouse (8, 13, 15) , suggesting that altered hepatic copper metabolism is a feature of Menkes' syn-24 h after copper administration, so that early hepatic copper fluxes were not determined. In studies by Mann et a/. (12) and Packman et al. (8) , distribution of 6 4 C~ in various organs in the mottled mouse was measured. Both investigators observed comparable hepatic 6 4 C~ uptake in normal and mutant mice and rapid loss of the radiocopper so that by 24 h postinjection, mutant hepatic 6 4 C~ levels were lower than control levels. These studies suggested a normal hepatic copper uptake, but abnormal copper retention in the mottled mouse. In studies by Mann et al. (12) , reductions in biliary copper concentrations were noted in brindled mutant mice.
We investigated biliary copper excretion and hepatic copper uptake using 6 4 C~ in the mottled (Mob'") mouse. Our results show a striking reduction in the biliary excretion of radiocopper by the mutant mouse under controlled experimental conditions. The i.v. infusion of fluids and sodium taurocholate, the major bile salt found in mice, maintained bile flow and biliary bile acid concentration at physiologic levels in both mutant and control animals throughout the course of the experiment. Radiocopper was i.v. pulse-injected, ensuring uniform systemic delivery of the 6 4 C~. It is unlikely that the differences in biliary copper excretion can be explained by differential hepatic copper levels because the control and mutant animals were matched for age and wt, and no difference in hepatic 64Cu content was noted 8 h after radiocopper administration. These results imply the presence of a biliary copper excretory defect in the mottled mouse, and, by analogy, in human KHS. If such a defect does, in fact, exist in human KHS, then a mechanism is suggested to explain the prolonged radiocopper biologic half-lives described in KHS patients by Dekaban et a/. (19) . Although the pattern of biliary copper excretion in the control male (Fig. 4) differed from that of control females (Fig. 4) , most likely reflecting possible sex differences and lack of taurocholate infusions, the fully affected 496 CASTILLO ET AL.
hemizygote clearly excreted far less copper in bile compared with his male counterpart.
Our data on the hepatic uptake of 6 4 C~ confirm previous findings in liver (8, 13, 15) and in fibroblasts (26). On direct evaluation of liver radiocopper content by serial liver biopsy, no difference was found between mutant and control animals. These data demonstrate that within the limits of the experimental methods used in this study, the mutant liver demonstrated no defect in copper uptake.
If our analogy is correct, and there is defective hepatic copper excretion in KHS, then the characteristically low liver copper levels in KHS must be explained. The pathogenesis of the low hepatic copper levels in KHS may be related to dynamic factors affecting total body metabolism of copper: decreased delivery of copper to liver and other organs due to the intestinal block in copper absorption; excessive avidity of extrahepatic tissues for copper; and continued copper loss as ceruloplasmin, with the liver being the only organ able to so export the metal into the circulation. The above combination would result in a strong tendency toward hepatic copper depletion in KHS.
Because of normal hepatic ceruloplasmin metabolism and characteristic low hepatic copper content found in KHS, it has been unclear whether the liver is a tissue that expressed the mutation. In one study. abnormal subcellular distribution of bile. Because the KHS mutation involves a different chromo-18. Evans GW, Reis BL 1978 Impaired copper homeostasis in neonatal male and soma1 locus, these two genetic diseases may affect different steps into the biochemistry and cell biology of hepatic copper disposition. The basic defect in KHS remains unknown, but the manifestations of the syndrome are thought to involve low cuproenzyme activity in tissues with deficient copper content and defective copper use in tissues expressing the mutant phenotype of copper sequestration (5-7). Whereas concentrations of metallothionein, a major intracellular copper-binding protein, are increased in KHS cells expressing the copper sequestration phenotype, the regulation of copper-binding metallothionein is normal in KHS.
